Summary During our studies of DNA fingerprinting of tumours of the pancreas and papilla (ampulla) of Vater, using arbitrarily primed polymerase chain reaction (AP-PCR), we noticed two bands showing a decreased intensity in six of ten ampullary tumours with respect to matched normal tissues. Those bands were both assigned to chromosome 5. Such a finding was somewhat in contrast with the reportedly low frequency of APC gene mutations in ampullary cancers, located at chromosome 5q21, and suggested that loci different from that of APC might be the target of chromosome 5 allelic losses (LOH) in these tumours. Therefore, we analysed chromosome 5 LOH in a panel of 27 ampullary tumours, including eight adenomas, four earty-and 15 advanced-stage cancers, using 16 PCR-amplified CA microsatellite polymorphic markers spanning the entire chromosome. Nineteen cases (70%/a) showed LOH, and the interstital deletions found in these tumours described two smallest common deleted regions, in which putative suppressor genes might reside. They were at 5q13.3-q14 and at 5q23-q31 respectively, which correspond to those found in gastic tumours. In additon, the presence of 5q LOH in six of eight adenomas and in three of four earty-stage cancers suggests that such phenomena occur at earty stages of neoplastic progression of the ampullary epithelium.
It is widely accepted that accumulation of genetic changes underlies the development of cancer. However. there is evidence that it is not simply the accumulation of mutations. but also their order. that determines the propensity for neoplasia. and that only a subset of the genes that can affect cell growth can actually initiate the neoplastic process (Kinzler and Vogelstein. 1996) . Progress in understanding the pathogenesis of different malignancies will in large part depend on identifying the early genetic anomalies involved in the initiation of neoplastic transformation. The earliest genetic event in the great majority of colorectal cancers is inactivation of the adenomatosis polyposis coli (APC) gene (Jen et al. 1994) . However. APC gene mutation seems not to be a steplimiting event of neoplastic progression in gastrointestinal cancers other than colorectal. In fact. APC mutations are infrequent in oral. oesophageal. gastric. pancreatic and liver cancer. and. with the possible exception of Ki-ras mutations in pancreatic cancer. the earliest genetic alteration in these malignancies has not yet been discovered (Honi et al. 1992a: b; McKie et al. 1993; Ogasawara et al. 1994 : Seymour et al. 1994 : Uzawa et al. 1994 ; Yashima et al. 1994 : Hahn et al. 1995 .
During our studies of DNA fingerprinting of cancers of the pancreas and of the papilla (ampulla) of Vater. using arbitrarily primed polymerase chain reaction (AP-PCR). we noticed two bands showing a decreased intensity in six of ten ampullary tumours. including one adenoma. with respect to matched normal tissues. It has been demonstrated that decreased intensity of AP-PCR bands in tumour DNA reflects allelic losses. whereas increased band intensity indicates the presence of extra copies of these sequences (Achille et al. 1996a ; Peinado et al, 1992) . The two AP-PCR bands were both assigned to chromosome 5. Such information led us to analyse the entire chromosome 5 for the presence of allelic losses (LOHs) in a panel of ampullary tumours. in addition to the fact that our previous observation of a low frequency of APC gene mutations in these cancers (Achille et al. 1996b) suggested that the APC gene. located at chromosome 5q2 1, might not be the exclusive or most important target of chromosome 5 deletions in ampullary tumours. In this respect. it is worthy of note that no structural abnormality of chromosome 5 had been reported in the nine ampullary or periampullary carcinomas in which cytogenetic analysis was performed (Johansson et al. 1992 : Bardi et al. 1993 . Molecular techniques are more sensitive than cytogenetic analysis in detecting loss of genetic material.
wherever it is located. either in its natural position or in the context of complex translocations. and in determining the smallest common deleted regions (SCDRs) involved in those alterations. These methods are based on the detection of LOH at chromosomespecific polymorphic sites in DNA extracted from tumour, when compared with DNA from matched normal tissues. Such 'allelotyping' is feasible by PCR amplification of microsatellite repeats. provided the heterozygosity for the studied loci and neoplastic cellularity are higher than 50-60% in the cancer sample (Louis et al. 1992 ).
We explored chromosome 5 LOH in 27 ampullary tumours, including eight adenomas. using PCR amplification of matched normal and cancer DNAs with a set of CA microsatellite repeatspecific primers. Our results indicate that chromosome Sq LOH is frequent (70%) in ampullary tumours, and point to the presence of two different SCDRs. away from the APC locus and similar to Yasuda et al, 1996) . To confirm the assignment of bands A and G, the simultaneous hybridization of AP-PCR DNA fingerpnrnting product (SHARP)
analysis was used (Yasuda et al. 1996) . In this method. DNA fingerprints generated from human-rodent monochromosome cell hybrids are electroblotted on to a nylon membrane and hybridized to radioactively labelled human AP-PCR products obtained with that of the non-neoplastic tissue DNA by a factor of at least 1.5 (Achille et al. 1996a AP-PCR Among the consistent abnormalities noticed in replicate experiments of AP-PCR fingerprints of ampullary cancers, two nonpolymorphic bands, named A and G. showed a decrease in intensity in 60% of cases, including five cancers (AT2, AT5, AT 14. AT15 and AT29) and one adenoma (AT17) (Figure 1 ). No change in band A and G intensity was consistendly seen in cancer AT3 and in adenoma ATIl, whereas cancers AT20 and AT22 showed an increase in the intensity of band A.
Chromosomal lcalzation of bands A and G by AP-PCR fingerprint
The PCR amplification with AR-3 primer of DNA from monochromosomal human-rodent cell hybrid panel no. 2 allowed the assignment of bands A and G to chromosome 5 (Figure 2 ). Such assignment was confirmed by SHARP analysis (Figure 3 ). Figure 6 ). NI, not informative; NA, not amplified.
( Figure 6 ). (Scarpa et al. 1993a .b: Achille et al. 1996b LOH is the complete inactivation of APC function by mutation of one allele and the loss of the other in about 15% of cases. such as in adenoma AT17 and cancers AT14 and AT19. On the other hand. the absence of APC mutations in the majority of cases and the finding of two SCDRs at regions different from 5q2 1 suggest that tumour-suppressor genes other than APC might be involved.
The presence of a tumour-suppressor gene different from APC on chromosome Sq is suggested by several lines of evidence, including the detection of frequent Sq deletions by either cytogenetic or molecular techniques in different types of neoplasm. In particular. fine mapping of chromosome Sq losses identified the same two SCDRs described by our cases in gastric cancer (Tamura et al. 1996) , and the 5q23-q31 SCDR in oesophageal carcinomas (Ogasawara et al, 1996) . In addition, the 5q13.3-q14 SCDR has also been found in ovarian, lung and male germ tumours (Murty et al. 1996 : Tavassoli et al. 1996 : Wieland et al, 1996 , whereas the 5q23-q31 SCDR has also been described in acute myelogenous leukaemia and myelodysplastic syndrome, in which deletions are centred at band 5q31 (Horrigan et al, 1996) . In this region, and precisely to 5q31.1. the IRF-1 gene has been identified as a possible candidate tumour-suppressor gene (Willman et al, 1993) .
as it was able to revert the oncogenic transformation of the NIH3T3 cell line induced by IRF-2 overexpression . However, other genes that locate near IRF-1. such as the cytokine genes IL-3. IL-4. IL-S. GM-CSF and the mitotic inducer CDC25C gene may be the target of 5q3 1 LOH.
Ampullary cancer is an uncommon disease. Yet. it accounts for about 36% of pancreaticoduodenal surgical demolitions. and the decision as to whether it should be viewed as a gastrointestinal or as a peripancreatic cancer. together with biliary tract tumours. is unclear (Brennan. 1990 ; Klempnauer et al, 1995 : Rose et al. 1996 . This is not only a theoretical question. as it also involves debate about use of surgical and/or chemotherapeutic treatment. Our present data in conjunction with previous studies on ras and APC mutations and microsatellite instability (Scarpa et al. 1993b (Scarpa et al. . 1994 Achille et al. 1996b Achille et al. . 1997 . give further support to the view that the molecular pathogenesis of ampullary cancers is more similar to that of gastric cancers than to that of pancreatic cancers (McKie et al. 1993; Seymour et al. 1994; Tamura et al, 1994; Yashima et al. 1994) . by also showing a similar frequency of chromosome 5 LOH and overlapping SCDRs (Tamura et al. 1996) . The similarity of ampullary cancers with gastric malignancies and their difference from pancreatic cancers also encompasses the clinical behaviour. as suggested by two studies (Brennan. 1990; Klempnauer et al. 1995 
